Monday, September 02, 2019 2:00:11 PM
North40000 re:
Here North4000 is my specific reply:
I have not looked at the Technical Picture of ANRN for a long time.
Putting on My Technical Hat (see below) another skill set acquired over the many years of technical chart reading from briefings from the best(were my Merrill Lynch brethren’s 20 ft away!:
https://investorshub.advfn.com/boards/profile.aspx?user=486527&page=4
Impressive those late trades but modestly above AMRN lows of the day!
Clearly AMRN has established an interim bottom from a precipitous drop from $23 and has a short term constructive net accumulation with improving technical indicators like MACD, Fast Stochastic, Money Flow as it is filling in that Down Gap from $17.
Hopefully there is some ground breaking AMRN announcement after Labor Day!
AMRN’s technical indicators like ADX Plus needs to IMPROVE and
break that sharp interim decline line,
AND penetrate above $18 (50/200 DMA; GOLDEN CROSS !)
DIFFERENT STROKES FOR DIFFERENT FOLKS
What does that ~ 71000+ block at 4 pm tell you, share price $14.99, with the dribs and drabs of 4, 10, 1, 3 shares following in the next minute?
Here North4000 is my specific reply:
I have not looked at the Technical Picture of ANRN for a long time.
Putting on My Technical Hat (see below) another skill set acquired over the many years of technical chart reading from briefings from the best(were my Merrill Lynch brethren’s 20 ft away!:
Technical Analysis is but A Tool that I use ONLY as a Confirmatory indicator backing up the varying conduits of Fundamental Security Analysis.
https://investorshub.advfn.com/boards/profile.aspx?user=486527&page=4
Impressive those late trades but modestly above AMRN lows of the day!
Clearly AMRN has established an interim bottom from a precipitous drop from $23 and has a short term constructive net accumulation with improving technical indicators like MACD, Fast Stochastic, Money Flow as it is filling in that Down Gap from $17.
Hopefully there is some ground breaking AMRN announcement after Labor Day!
AMRN’s technical indicators like ADX Plus needs to IMPROVE and
break that sharp interim decline line,
AND penetrate above $18 (50/200 DMA; GOLDEN CROSS !)
DIFFERENT STROKES FOR DIFFERENT FOLKS
DIFFERENT STROKES FOR DIFFERENT FOLKS
Recent AMRN News
- Amarin Highlights New REDUCE-IT Analysis Showing Risk-Weighted ApoB May Improve Cardiovascular Risk Detection (AMRN) • IH Market News • 05/27/2026 03:24:38 PM
- New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia • GlobeNewswire Inc. • 05/27/2026 12:00:00 PM
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
